Mar 3, 2021
Marija Butkovic – ForbesWomen It’s no secret that the venture capital industry is too male-dominated, which is a result of many factors – unconscious biases, stereotypes, the ‘motherhood penalty’, not recruiting enough candidates from...
Feb 23, 2021
VANCOUVER, Wash., Feb. 22, 2021 /PRNewswire/ — AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, today announced a strategic equity investment by Merck Global Health Innovation Fund (Merck GHI) and...
Feb 5, 2021
Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of $153 million. Friday’s Wall Street debut was a show of confidence, upsized from an original plan to offer...
Feb 5, 2021
Feb. 5, 2021 04:27 UTC EMERYVILLE, Calif.–(BUSINESS WIRE)– Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today...
Jan 22, 2019
Cavallo Ventures, the venture capital arm of global agribusiness company Wilbur-Ellis, has just announced a seven figure investment in agricultural technology startup Crop Enhancement, Inc. The California-based company makes CropCoat, a unique protective coating being...
Jan 22, 2019
The venture capital arm of Wilbur-Ellis–a recognized leader in the marketing and distribution of crop protection, precision agriculture technology, seed and nutritional products–aims to accelerate the application of sustainable crop protection technologies...
